Lucitanib

Clovis spikes ovarian cancer combo after 'underwhelming' efficacy; Servier wins priority review for Tibsovo expansion
Endpoints
Wed, 05/5/21 - 10:42 am
Clovis Oncology
earnings
Lucitanib
Opdivo
Bristol Myers Squibb
ovarian cancer
4 Key FDA Decisions Expected By Year End
24/7 Wall St
Sun, 11/29/15 - 12:43 pm
FDA
Achillion
hepatitis C
Biocryst
OPuS-2
BCX4161
Tetraphase Pharmaceuticals
Lucitanib
Clovis Oncology
Why Clovis Oncology Was Up 10% In After-Hours Trading Yesterday
Bidness Etc.
Thu, 09/11/14 - 08:20 am
Clovis Oncology
breast cancer
Lucitanib
Clovis Oncology Announces Encouraging Data from Phase 1/2a Study Evaluating Lucitanib in Advanced Solid Tumors
Yahoo/BusinessWire
Sat, 05/31/14 - 10:09 am
Clovis Oncology
Lucitanib
breast cancer
non-small cell lung cancer
3 Biotechs Generating a Lot Of Buzz
Wall St Cheat Sheet
Mon, 01/13/14 - 02:47 pm
Celgene
Arrowhead Research
Clovis Oncology
ARC-520
CO-1686
Lucitanib
rucaparib